Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study to Determine Time to Steady-state of an Oral Testosterone Undecanoate Formulation in Hypogonadal Men.

NCT00911586 is registered in ClinicalTrials.gov with Clarus Therapeutics, Inc. as lead sponsor.

NCT NCT00911586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00911586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study to Determine Time to Steady-state of an Oral Testosterone Undecanoate Formulation in Hypogonadal Men.
Lead sponsor
Clarus Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2009
Completion date
January 31, 2010
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

male hypogonadism, primary hypogonadism, secondary hypogonadism